(VIANEWS) – ING GROEP N.V. (INGA.AS), SPAREBANK 1 SØRØ (SOON.OL), MEDISTIM (MEDI.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ING GROEP N.V. (INGA.AS)
24.2% sales growth and 25.17% return on equity
ING Groep N.V., a financial institution, provides various banking products and services in the Netherlands, Belgium, Rest of Europe, North America, Latin America, Asia, and Australia. It operates in six segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The company accepts various deposits, such as current and savings accounts. It also offers business lending products; consumer lending products, such as residential mortgage loans, term loans, and other consumer lending loans; and secured and unsecured lending services. in addition, the company provides debt capital market, working capital solutions, export finance, daily banking, treasury and risk, and corporate finance solutions; and specialized lending, debt and equity market solutions, payments and cash management, and trade and treasury services, as well as savings, investment, insurance, mortgage, and digital banking services; and SME loans. It serves individual customers, corporate clients, and financial institutions. ING Groep N.V. was founded in 1762 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ING GROEP N.V. has a trailing twelve months EPS of €1.35.
PE Ratio
ING GROEP N.V. has a trailing twelve months price to earnings ratio of 8.92. Meaning, the purchaser of the share is investing €8.92 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.17%.
Volume
Today’s last reported volume for ING GROEP N.V. is 1394960 which is 90.86% below its average volume of 15267200.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.8%, now sitting on 31.29B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 45.2% and 76.9%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.56 and the estimated forward annual dividend yield is 4.68%.
More news about ING GROEP N.V..
2. SPAREBANK 1 SØRØ (SOON.OL)
19% sales growth and 10.73% return on equity
SpareBank 1 Sørøst-Norge provides various banking products and services for private and corporate customers in Norway. The company offers mobile and online banking, card, account, and payment services. It also provides mortgage, car, boat, consumer, and other vehicle loans as well as refinancing, micro savings, investment, pension, and property related services. In addition, the company offers daily operations, get paid, loans and financing, and pension related products. Further, it provides business and personnel insurance as well as savings and investment products. The company was founded in 1859 and is headquartered in Sandefjord, Norway.
Earnings Per Share
As for profitability, SPAREBANK 1 SØRØ has a trailing twelve months EPS of kr4.79.
PE Ratio
SPAREBANK 1 SØRØ has a trailing twelve months price to earnings ratio of 10.44. Meaning, the purchaser of the share is investing kr10.44 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.73%.
More news about SPAREBANK 1 SØRØ.
3. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.45.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 39.22. Meaning, the purchaser of the share is investing kr39.22 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 499.39M for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 25, 2023, the estimated forward annual dividend rate is 4.5 and the estimated forward annual dividend yield is 1.79%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 17.7% and positive 11.1% for the next.
More news about MEDISTIM.
4. ITERA (ITERA.OL)
11.8% sales growth and 99.64% return on equity
Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, ITERA has a trailing twelve months EPS of kr0.81.
PE Ratio
ITERA has a trailing twelve months price to earnings ratio of 19.14. Meaning, the purchaser of the share is investing kr19.14 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 99.64%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 25, 2023, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 1.95%.
More news about ITERA.
5. IMCD (IMCD.AS)
6.5% sales growth and 19.97% return on equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €5.5.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing €24.9 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
Volume
Today’s last reported volume for IMCD is 17829 which is 85.81% below its average volume of 125665.
More news about IMCD.
